Oncology is the one place where the order set carries the treatment.

The RealityA regimen is a governed document, not a template

⚠️

The Problem

The library was built once and drifts.

Regimens copied from a guideline two years ago, edited locally by whoever needed a variation, with no record of what changed or who agreed it.

🔧

The Solution

Treat regimens as governed documents.

Named owner, approval step, version number, effective date and a change log — the same apparatus a policy gets, applied to something more dangerous.

✅

The Resolution

A library you can defend and update.

Changes are deliberate and dated, variations are visible, and you can say which version of a regimen a given patient was treated under.

Regimen build: what a standard plan actually contains

A complete regimen is longer than most people expect. The agents and their doses. The basis for each dose — flat, per square metre, per kilogram, or by area under the curve. The sequence and the infusion times. Premedications and hydration. Growth factor support. The laboratory parameters checked before each cycle and the thresholds at which a cycle is held or reduced. The cycle length and the planned number of cycles.

Every one of those is a decision someone made. Writing them into the library makes them consistent; leaving them out means each prescriber reconstructs them, which is precisely the variation the library exists to remove.

This is also where the build effort actually sits. Encoding the agents is quick. Encoding the hold and reduce rules is slow, contested, and the part that delivers most of the safety value.

Version control is the whole discipline

Ask any oncology practice which version of a regimen a patient treated eighteen months ago received, and watch what happens. In most, the answer is not retrievable, because the regimen was edited in place.

That is the gap. A regimen library needs the apparatus of a controlled document: a version number, an effective date, a named owner, an approval record, and a change log that survives the change. Without it there is no way to reconstruct what the system told a prescriber on a given day, which matters clinically and matters more if anyone ever asks.

The practical rule is that regimens are superseded rather than edited. The old version stays, marked inactive, with its dates. Storage is cheap and the alternative is an unanswerable question.

Dose rounding, and the decision nobody wrote down

Calculated doses arrive with impractical precision. A body-surface-area calculation produces a number to several decimal places, and somebody has to decide what is actually prepared.

Most practices round. Few have written down the rule, and fewer have encoded it, which means it varies by pharmacist and by day. That variation is invisible until someone compares two patients on the same regimen and finds different doses with no documented reason.

Write the rounding rule down, agree it through the same committee that approves regimens, encode it, and record the calculated dose alongside the prepared dose so the difference is visible rather than lost. This is ordinary configuration work, and it removes a whole category of unexplained variation.

Hazardous drugs and what the library has to flag

A regimen library is also the natural place to carry handling information, because it is the object everybody touches.

NIOSH publishes the reference list here. The NIOSH List of Hazardous Drugs in Healthcare Settings, 2024, publication 2025-103, is designed to help healthcare workers and employers identify which drugs routinely handled by employees are considered hazardous. Relative to the 2016 list it added 25 drugs and removed 7.

Those numbers are the argument for governance rather than a one-time build. A list that changes is a list your library has to be reconciled against on a schedule, by someone whose job that is. Reconciling annually is a modest task; discovering after three years that nobody has is not.

Order sets and the limits of standardisation

There is a tension worth naming. A library exists to standardise, and oncology is full of legitimate reasons to deviate — renal function, age, prior toxicity, a trial protocol, a patient’s own goals.

A library that forbids deviation gets worked around, usually by prescribing outside it entirely, which is worse than the variation it was preventing. A library that permits silent deviation records nothing. The workable middle is deviation that is easy, visible and captured: prescribe from the regimen, modify with a reason, and let the reason be reportable.

Reviewing those reasons quarterly is the single most useful governance activity we see. A modification made repeatedly for the same reason is not a deviation — it is a variant the library should carry, and promoting it removes the workaround. That review sits naturally alongside the wider ordering workflow rather than as a separate meeting.

Where the payment models point

There is external pressure toward exactly this discipline. CMS’s Enhancing Oncology Model requires participating practices to undertake a set of care redesign activities that include using evidence-based treatment guidelines, maintaining comprehensive care plans, collecting electronic patient-reported outcomes, and using certified EHR technology, with a monthly enhanced oncology services payment of $110 per beneficiary and $140 for dually eligible beneficiaries.

A governed regimen library is how “evidence-based treatment guidelines” stops being a statement and becomes something demonstrable. Whether or not you participate in that model, it describes where the expectations are heading.

On the drug side the ground is also moving. FDA’s August 2024 guidance on optimising the dosage of oncology drugs and biological products is aimed at sponsors during clinical development rather than at practices, but it signals more dosage refinement arriving over time — which is more library maintenance, not less.

• Give every regimen an owner, a version and an effective date. Supersede, never edit in place.
• Write the dose rounding rule down and encode it. Record calculated and prepared doses.
• Reconcile against the hazardous drugs list annually. It changes.
• Review modification reasons quarterly. Repeated deviations are missing variants.

Qventive provides chemotherapy regimen EHR library services in Hackensack NJ and across the surrounding counties, as part of our oncology EHR and IT support and a broader oncology practice management engagement. Because the library drives orders against identifiable patients, its change control belongs in your HIPAA risk analysis alongside your clinical governance.

Regimen libraries: common questions